The Long-Evans Tokushima Lean (LETL) rat, characterized by rapid onset of insulindependent (type I) diabetes mellitus (IDDM), no sex difference in the incidence of IDDM, autoimmune destruction of pancreatic beta cells, and no significant T cell lymphopenia, is a desirable animal model for human IDDM. We have established a diabetes-prone substrain of the LETL rat, named Komeda Diabetes-Prone (KDP) rat, showing a 100% development of moderate to severe insulitis within 220 d of age. The cumulative frequency of IDDM was 70% at 120 d of age, and reached 82% within 220 d of age. Here, we performed the first genome-wide scan for non-MHC IDDM susceptibility genes in this strain. The analysis of three crosses has led to the revelation of a major IDDM susceptibility gene, termed Iddm/kdp1, on rat chromosome (Chr) 11. Homozygosity for the KDP allele at this locus is shown to be essential for the development of moderate to severe insulitis and the onset of IDDM. Comparative mapping suggests that the homologues of Iddm/ kdp1 are located on human Chr 3 and mouse Chr 16 and would therefore be different from previously reported IDDM susceptibility genes. 
Introduction
Whole genome genetic dissection of polygenic traits has become possible recently in the human and mouse with the development of detailed genetic maps, particularly with the use of simple sequence length polymorphism (SSLP) 1 /microsatellite markers. Although the rat genetic map was rudimentary compared with those of the human and mouse, significant progress has been made in the past years (1) (2) (3) .
Insulin-dependent (type I) diabetes mellitus (IDDM) is an autoimmune disease with multifactorial etiology, and it has become a target of comprehensive genetic analyses in humans and animals. So far, several IDDM susceptibility genes have been mapped in these species (4) (5) (6) (7) (8) . In the nonobese diabetic mouse, at least 15 different loci are linked to disease development (8, 9) , and studies to identify these genes are undertaken with congenic strategy and/or the positional candidate gene approach. The BB rat is another well-studied model for IDDM. At least three genes are involved in the development of the disease: Lyp ( Iddm1 ), which controls T cell lymphopenia, an MHC-linked gene ( Iddm2 ), and the third gene ( Iddm3 ) (5, (10) (11) (12) . Although these animal models have contributed to the understanding of IDDM, some characteristics of human IDDM are not fully covered by these models. Other animal models with characteristics different from those of the nonobese diabetic mouse and the BB rat are therefore essential for the elucidation of the human disorder.
The Long-Evans Tokushima Lean (LETL) rat is among the best models for this disorder. The characteristics are rapid onset of overt diabetes with no sex difference in the incidence, autoimmune destruction of pancreatic ␤ cells, and no significant T cell lymphopenia (13) . The cumulative frequency of diabetes had been maintained at Ͻ 30% to avoid a transition to high frequency of diabetes, which resulted in poor reproductive performance (13) . The first genetic analysis showed that at least two recessive genes are responsible for the induction of insulitis, one of which is closely linked with rat MHC RT1 u haplotype (13) .
To make the LETL rat a fully usable model of IDDM, the frequency of diabetes must be elevated. Therefore, we have begun to isolate a diabetes-prone substrain from the LETL rat. Briefly, selective brother-sister mating has been conducted using diabetic animals or nondiabetic ones but with severe insulitis. The cumulative frequency of diabetes in the animals generated from diabetic parents was 70% at 120 d of age, and reached 82% within 220 d of age. It was noteworthy that all nondiabetic animals developed moderate to severe insulitis within 220 d of age. Since these characteristics are apparently different from those of the LETL rat, we named the diabetesprone substrain Komeda Diabetes-Prone (KDP) rat.
In this study, we report on the first genome-wide scan for non-MHC IDDM susceptibility genes in the KDP rat. The results show that a novel non-MHC gene, termed Iddm/kdp1 , on rat chromosome (Chr) 11 is essential for the development of moderate to severe insulitis and the onset of diabetes.
Methods
Cross. The LETL and Long-Evans Tokushima Otsuka (LETO [13] , a control strain without any diabetic symptoms derived from the same origin as the LETL) rats were obtained from Dr. K. Kawano (Tokushima Research Institute, Otsuka Pharmaceutical Co., Tokushima, Japan). The Brown Norway (BN/Sea) rat was purchased from Seiwa Experimental Animals Co. Ltd. (Fukuoka, Japan). The Tester Moriyama (TM/Kom) rat was maintained at the Animal Research Center, Tokyo Medical College. All rats were maintained under specific pathogen-free conditions with a 12-h light/dark cycle, FR-1 commercial diet (Funabashi Farm Co. Ltd., Chiba, Japan), and water ad libitum at the same facility.
The KDP rat was developed as a diabetes-prone substrain of the LETL rat by selective brother-sister mating, and only diabetic males were used to generate backcross progeny with the three reference strains, the TM, LETO, and BN rats: (TM ϫ KDP)F1 ϫ KDP, (LETO ϫ KDP)F1 ϫ KDP and (BN ϫ KDP)F1 ϫ KDP. All crosses were conducted under specific pathogen-free conditions in the same facility. Rat MHC RT1 haplotypes of the KDP, TM, LETO, and BN rats are u, u, u, and n, respectively. All animal care and procedures were approved by the Steering Committee of Research-Related Laboratory Animals of Tokyo Medical College.
Phenotyping. The F1 and backcross progeny were phenotyped for insulitis and diabetes as follows. Animals were checked for glycosuria three times a week by Tes-tape (Eli Lilly and Co., Indianapolis, IN) until 120 d of age. Nonfasting blood glucose levels of glycosuric animals (2 to 4 ϩ ) were measured on tail blood by Glutest E (Kyoto Daiichi Chemicals Co. Ltd., Kyoto, Japan). Diabetes was defined as 2 to 4 ϩ glycosuria and blood glucose levels Ͼ 200 mg/dl under ad libitum dietary conditions. Diabetic animals were treated with 2-5 U/d of Ultralente insulin (Novo-Nordisk Pharmaceutical Co. Ltd., Bagsvaerd, Denmark) in the evening for survival.
Four blocks from the whole pancreas of each animal were fixed in Bouin's solution. 5-m paraffin sections were prepared and stained with hematoxylin and eosin. Light microscopic observations of the serial sections were done by examiners with no information concerning the diabetic status of the animals. First, each pancreatic islet was graded from intact to severe: an islet having no intraislet infiltration cells being considered as intact, a slightly infiltrated islet as slight insulitis, a clearly infiltrated islet as mild insulitis (area of infiltration/islet area Ͻ 25%), a markedly infiltrated islet as moderate insulitis (25% Ͻ area of infiltration/islet area Ͻ 75%), and a severely infiltrated islet as severe insulitis (75% Ͻ area of infiltration/islet area).
Then, the degree of insulitis of each animal was graded from 1 to 5 based on the percentages of moderately and severely infiltrated islets. Animals with no or slight insulitis were given a score of 1. A score of 2 was given to those with Ͻ 10% severely and Ͻ 50% moderately infiltrated islets. A score of 3 was given to those with Ͻ 10% severely and Ն 50% moderately infiltrated islets, with Ն 10% but Ͻ 30% severely infiltrated islets, or with Ն 30% but Ͻ 50% severely and Ͻ 50% moderately infiltrated islets. A score of 4 was given to those with Ն 30% but Ͻ 50% severely and Ն 50% moderately infiltrated islets, or with Ն 50% but Ͻ 70% severely infiltrated islets. Those with Ն 70% severely infiltrated islets were classified as end-stage infiltration and were given a score of 5.
Genotyping. Genotyping was performed using SSLP markers described elsewhere (2, 3, (14) (15) (16) (17) (18) (19) , with the exception of D20Rwh1 which was detected by PCR-RFLP analysis (5) and D17Kyo1 which was revealed by arbitrarily primed-PCR analysis (20) . To genotype backcross progeny, genomic DNA (80 ng) samples were amplified by PCR. PCR conditions were as follows: 50 mM KCl, 20 mM Tris-HCl (pH 8. using the following thermocycling protocol: initial denaturation at 94 Њ C for 3 min, followed by 35 cycles of 94 Њ C for 30 s, annealing for 1 min and 72 Њ C for 45 s, with a final extension period, 72 Њ C for 5 min. Optimized annealing temperatures ranged from 50 to 60 Њ C. PCR products were mixed with loading buffer (0.05% bromophenol blue, 50% glycerol), electrophoresed on 4% NuSieve 3:1 agarose gels (FMC BioProducts, Rockland, ME), and stained with ethidium bromide. Although most of the alleles were detected by this type of analysis, some of them were not resolved. In this case, radiolabeled PCR products were run on sequencing gels. DNA fragments were amplified in a reaction volume of 25 l containing 100 ng of genomic DNA, 50 mM KCl, 20 mM Tris-HCl (pH 8.4), 1-2 mM MgCl 2 , 0.05% W-1 buffer, 20 M each of dATP, dGTP, and dTTP, 2 M of dCTP, 1 Ci [ ␣ -32 P]dCTP (6,000 Ci/mmol), 200 nM each of primers, and 0.5 U Taq DNA polymerase, overlaid with 50 l of mineral oil. Amplifications were performed in a DNA thermal cycler (Perkin Elmer Cetus Corp., Norwalk, CT) using the thermocycling protocol as described above. After amplifications, PCR products were mixed with 20 l of formamide buffer (95% formamide, 0.05% bromophenol blue, 0.05% xylene cyanol, 20 mM EDTA), heated at 94 Њ C for 5 min, cooled immediately to 4 Њ C, loaded on 5% polyacrylamide, 7 M urea sequencing gels, and electrophoresed at 2,000 V for 2 h. The gels were dried down, exposed overnight, and visualized by autoradiography.
Linkage analysis. The segregation patterns of the markers in the backcross progeny were analyzed with the Map Manager computer program (21) . Linkage of markers to diabetes was evaluated by 2 tests in 2 ϫ 2 contingency tables.
Comparative mapping. Two mouse markers, D16Mit4 and D16-Mit77 , were applicable to the rat as the same primers for the mouse, whereas primers for D16Mit46 were newly designed as follows: 5 Ј -TTTAACTTGAATTTCACTGT-3 Ј and 5 Ј -AGAATAAT-TCCAGACATCAA-3 Ј . For genotyping by mouse SSLP markers, the same protocol was used, as described above. We genotyped (ALY ϫ MSM)F1 ϫ ALY mouse backcross sets (22) for mapping a rat marker, D11Mgh5 , on mouse Chr 16. Rat Gap43 and Sod1 gene sequences were obtained from GenBank, and primers flanking microsatellite were designed as follows: Gap43 , 5 Ј -ACCTCTATG-CGGTTTTAGAT-3 Ј and 5 Ј -AGTTACAGCTGCCAGGAGAT-3 Ј ; Sod1 , 5 Ј -ACAATTCCTGAATGTGTACAACTCT-3 Ј and 5 Ј -AGC-TCTAAATAAGTCTCAGTCTCTC-3 Ј .
Results

Inheritance of diabetes and insulitis.
To investigate the genetic control of insulitis and diabetes in the KDP rat, we generated two MHC-matched backcrosses, (TM ϫ KDP)F1 ϫ KDP and (LETO ϫ KDP)F1 ϫ KDP (termed TM cross and LETO cross, respectively), in which both the TM and LETO rats have the same MHC haplotype (RT1 u ) as the KDP rat. We also generated one MHC-mismatched backcross, (BN ϫ KDP)F1 ϫ KDP (termed BN cross), in which the BN rat has a different MHC haplotype (RT1 n ). In the F1 generation, most of the animals were free from insulitis, some of them showed only slight insulitis, and none of them developed overt diabetes (data not shown). The cumulative frequency of diabetes in the backcross progeny varied with the cross (Fig. 1) . At 120 d of age, 32 and 34% of the animals in the TM and LETO crosses developed diabetes, respectively, while 16% of the animals in the BN cross developed diabetes. In the case of insulitis, the proportion of the animals classified as specific scores also depends on the cross. If the animals are divided into two classes, score 1 (no or slight insulitis, which corresponds to F1 type) and scores 2-5 (mild insulitis to end stage infiltration), the proportions of the animals with scores 2-5 were 51% in the TM cross and 46% in the LETO cross, while 35% in the BN cross.
A genome-wide scan for IDDM susceptibility genes. In an attempt to detect non-MHC IDDM susceptibility genes, we genotyped markers throughout the rat genome on the backcross progeny from the TM cross (Table I) . Since the TM cross is MHC-matched, MHC-linked genes should not segregate in this cross. In diabetic animals, two chromosomal regions, on Chr 2 ( D2Mit16 , 2 ϭ 4.0, P Ͻ 0.05) and Chr 11 (all markers, 2 Ͼ 12.4, P Ͻ 0.001), showed an excess of homozygotes, while two other regions, on Chr 2 ( Cpb , 2 ϭ 5.0, P Ͻ 0.05) and Chr 18 (Gja1 and Olf, 2 ϭ 5.3 and 4.9, respectively, P Ͻ 0.05), showed an excess of heterozygotes. Except for Chr 11, these distortions of genotypes in the progeny may reflect weak evidence of linkage or random fluctuations. In contrast, we detected strong evidence of linkage to diabetes on Chr 11 markers (D11M16Mit46, 2 ϭ 55.4, P Ͻ 0.001). The strong bias to homozygotes in diabetic animals suggests that there is one recessively acting diabetogenic gene in the vicinity of D11M16Mit46 locus. Assuming that this gene acts in a fully recessive manner and using the genotypes of diabetic animals only, the position of the gene, termed Iddm/kdp1, was accurately mapped between Mox2 and D11M16Mit46 (Fig. 2) . This means that all diabetic animals are homozygous for the KDP allele at the locus, and that Iddm/kdp1 acts in a recessive manner. These results, together with the inheritance pattern of diabetes described above, suggest that the inheritance of diabetes in the TM cross could be explained by the segregation of only one gene, Iddm/ kdp1.
To replicate these findings and to confirm the effect of an MHC-linked gene on insulitis and diabetes, we genotyped the animals generated from the other two crosses: the LETO and BN crosses (Table II) . In these crosses, strong evidence of linkage to diabetes was found in the same region on Chr 11 (D11Mgh5 in the LETO cross, 2 ϭ 64.8, P Ͻ 0.001; Mox2 in the BN cross, 2 ϭ 9.0, P Ͻ 0.005), and no evidence of linkage was detected in the other chromosomes (data not shown), except for MHC (RT1) locus in the BN cross (D20Rwh1, 2 ϭ 5.1, P Ͻ 0.05). As for the TM cross, the results indicate that all diabetic animals are homozygous for the KDP allele at Iddm/ Figure 1 . Cumulative frequency of diabetes in the parental KDP strain and the three backcrosses. The cumulative frequency of diabetes in the KDP strain was based on the animals generated from diabetic parents. kdp1 locus (Fig. 3) , and that Iddm/kdp1 acts in a recessive manner. In the BN cross, eight diabetic animals out of nine were homozygous for the KDP allele at MHC (Table II and Fig. 3) , suggesting that an MHC-linked gene would be associated with diabetes and acts in a mostly recessive manner. These results demonstrate that Iddm/kdp1 is a major diabetogenic factor in the KDP rat irrespective of the cross, and that the inheritance of diabetes could be explained by the segregation of Iddm/kdp1 in the MHC-matched crosses, the TM and LETO crosses, and by the segregation of Iddm/kdp1 and an MHC-linked gene in the MHC-mismatched cross, the BN cross.
The influence of Iddm/kdp1 on the development of insulitis. To reveal the effect of Iddm/kdp1 in the pathogenesis of diabetes, we investigated the influence of Iddm/kdp1 on insulitis (Table III) . Since all diabetic animals showed end-stage infiltration (score 5), association between insulitis scores in nondiabetic animals and genotypes at the closest markers to Iddm/ kdp1 locus was examined. In all three crosses, a significant number of nondiabetic animals homozygous for the KDP allele developed moderate to severe insulitis (scores 3-4), whereas those heterozygous remained intact or had mild insulitis (scores 1-2), with the only exception of one animal in the TM cross which developed moderate insulitis. These findings indicate that homozygosity for the KDP allele at Iddm/kdp1 locus is strongly associated with the development of moderate to severe insulitis, and that Iddm/kdp1 acts in a recessive manner. Thus, it is suggested that Iddm/kdp1 would influence the development of insulitis in the pathogenesis of diabetes.
Comparative mapping of Iddm/kdp1 region among the rat, mouse, and human. Next, we conducted comparative mapping of Iddm/kdp1 region among the rat, mouse, and human, to make clear as to whether the homologues of Iddm/kdp1 have been mapped in the human and mouse. This has been done by reciprocal use of SSLP markers between the mouse and rat (23) , and by development of rat gene markers. Based on the synteny information (24), we screened ‫ف‬ 100 SSLP markers on mouse Chr 16, and detected three markers, D16Mit4, D16Mit46, and D16Mit77, which could be applicable in the TM cross. As shown in Fig. 4 , those markers were successfully mapped on rat Chr 11. Conversely, we mapped a rat SSLP marker, D11Mgh5, on mouse Chr 16. Large segments of mouse Chr 16 have been shown to be homologous to human Ho, homozygote; He, heterozygote. Linkage of markers to diabetes was evaluated by 2 tests in 2 ϫ 2 contingency tables. Only 2 Ն 4 values are shown. Distances between loci are described in centiMorgans, calculated with the Map Manager program (21) . *The distance is not supported by a logarithm of odds of 2.0 or higher. Chr 3 or Chr 21 (24) . To clarify the synteny between rat Chr 11 and the human homologous regions, we mapped rat homologues of human Chr 3 or Chr 21 genes. These results, together with reported map locations of the human and mouse loci (24) , suggest that the homologues of Iddm/kdp1 are located in the region between Gap43 and D16Mit46 on mouse Chr 16 and in the human Chr 3p11-q13 region (Fig. 4) .
Discussion
In this study, we performed the first genome-wide scan for non-MHC IDDM susceptibility genes in the KDP rat. Based on the genetic analysis of the three crosses, we mapped a non-MHC insulitis and IDDM susceptibility gene, Iddm/kdp1, to rat Chr 11, and showed that Iddm/kdp1 acts in a recessive fashion. None of the heterozygous animals for the KDP allele at this locus appeared to develop moderate to severe insulitis, implying that homozygosity for the KDP allele at this locus would be essential for the development of moderate to severe insulitis and also for the onset of diabetes. However, a significant number of KDP homozygotes remained intact or had mild insulitis. This could be mainly due to the relatively short testing period used in this study. Therefore, at present, it was not clear if KDP homozygosity at Iddm/kdp1 locus is sufficient for the development of moderate to severe insulitis and the onset of diabetes. To clarify this issue, further study is needed, in which the testing period must be lengthened. Among the reported IDDM susceptibility genes in the rat, there are two non-MHC genes, Lyp (Iddm1) on Chr 4 (5) and Iddm3 on Chr 18 (11) , involved in the pathogenesis of IDDM in the BB rat. The map position of Iddm/kdp1 clearly demonstrates that Iddm/kdp1 is different from the two.
Comparative mapping among the rat and "map-rich" species such as the human and mouse would give us mapping information of the homologues of relevant genes or mutations. Even if the homologues have not been mapped in the human and mouse, it might be possible to detect potential candidate genes. Therefore, we conducted comparative mapping of Iddm/ kdp1 region among the rat, mouse, and human. The result shows that the homologues of Iddm/kdp1 would be located in the human Chr 3p11-q13 region and in the region between Gap43 and D16Mit46 on mouse Chr 16, in which none of the IDDM susceptibility genes have been mapped. This indicates that Iddm/kdp1 is a novel IDDM susceptibility gene. In the Iddm/ Comparative mapping of Iddm/ kdp1 region among the rat, mouse, and human. The rat map is a composite map constructed from data obtained in this study, calculated with the Map Manager program (21) . For the underlined loci, the map locations of the human homologues are listed to the left of the mouse map. The reciprocally used markers between the rat and mouse are indicated with bold characters. D16R11Mgh5 is a rat Chr 11 marker which was mapped to mouse Chr 16. Distances (in centiMorgans) from centromere for the mouse loci and the map locations of the human loci are based on the Mouse Genome Database (24) . The bar shown at the bottom right describes genetic distances of 10 cM, which fits for both the mouse and rat maps.
kdp1 homologous region in the human and mouse, there are some potential candidate genes, relevant mutations, or, to say the least, immunologically relevant genes. Aod1, involved in neonatal thymectomy-induced autoimmune ovarian dysgenesis, has been mapped on mouse Chr 16 (25) . The map position of Aod1 seemed to be proximal to Gap43 (25) , while Iddm/ kdp1 would be located in the region distal to Gap43, which weakened a possible relationship between Aod1 and Iddm/ kdp1. The others include Ly7 (lymphocyte antigen-7), CD80 (CD80 antigen, also known as CD28 antigen ligand 1 or B7-1 antigen), CD47 (CD47 antigen, also known as Rh-related antigen, integrin-associated protein, or MER6 antigen identified by mAb 1D8), and MOX2 (antigen identified by mAb MRC OX-2) (24, 26) . The present linkage and comparative maps will help us to apply a positional candidate gene approach to clarify whether these genes are involved in the pathogenesis of IDDM in the KDP rat. We generated the BN cross not only to replicate findings obtained from the TM cross, but to reveal the mode of inheritance of both Iddm/kdp1 and an MHC-linked gene. In the BN cross, the animals homozygous for the KDP allele at the closest marker flanking Iddm/kdp1 locus with the MHC genotypes u/u and u/n developed moderate to severe insulitis in 14 out of 16 cases and 3 out of 15 cases, respectively (P Ͻ 0.001 with Fisher's exact test), and developed overt diabetes in 8 out of 16 cases and 1 out of 15 cases, respectively (P ϭ 0.01 with Fisher's exact test). In contrast, none of the animals heterozygous for the KDP allele at Iddm/kdp1 locus developed moderate to severe insulitis. These findings indicate that the two genes, Iddm/ kdp1 and an MHC-linked gene, would contribute to most of the predisposition to insulitis and diabetes in the BN cross.
Although the present linkage and comparative maps including Iddm/kdp1 are relatively sparse, further detailed mapping could be performed with the help of newly developed markers. In the near future, a positional cloning or positional candidate gene approach should be applied to Iddm/kdp1. Furthermore, congenic strains with the KDP allele on different genetic backgrounds should be generated to facilitate detailed genetic studies. Since Iddm/kdp1 is one of the strongest diabetogenic factors ever reported, the identification and elucidation of Iddm/kdp1 would contribute to the understanding, prevention, and treatment of autoimmune diseases, including IDDM.
